Respiratory Chain Complex I Deficiency in Leber Hereditary Optic Neuropathy: Insights from Ophthalmologic and Molecular Investigations in Tunisia

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2024 Nov 23

PMID 39578757

Authors

Latifa Chkioua

Yessine Amri

Chayma Sahli

Tawfik Nasri

Mohamed Omar Miladi

Taieb Massoud

Sandrine Laradi

Mohamed Ghorbel

Hassen Ben Abdennebi

Affiliations

Soon will be listed here.

Abstract

Background: Leber hereditary optic neuropathy (LHON) is a mitochondrial DNA (mtDNA) rare disease due to the pathogenic variant of the NADH dehydrogenase enzyme. LHON is characterized by a sudden central vision loss due to focal degeneration of the retinal ganglion cell layer and optic nerve. Symptoms usually appear between the age of 18 and 35 years. Some individuals present the mtDNA mutations but not presented the LHON clinical features. The heteroplasmic or homoplasmic character of the mutations among patients explains why they develop the disease or not even though they carry the pathogenic variant.

Methods: This study was performed in collaboration with the department of ophthalmology of Farhat Hached Hospital, Sousse, Tunisia. Screening for the common mutations in Mt-ND1 gene (m.3460G > A), Mt-ND4 gene (m.11778G > A) and Mt-ND6 gene (m.14484T > C) was performed in five Tunisian families by standard RFLP PCR, followed by direct sequencing of the entire of these genes. Indeed, bioinformatics tools were used to predict the potential functional impact of the identified mutations on the Human mitochondrial respiratory complex I protein.

Results: one novel p.L601M (m.1413 C > A) and four previously reported mutations were identified in this study including: rs199476112G > A (m.11778G > A); rs202227543G > A (m.14258G > A); rs1603224763 (m.14510 dup) and NC_012920.1: m.3244G > C. In this present report, only one patient was found carrying the primary point mutation (m. 11778G > A). The ophthalmologic findings showing major fundus changes included hyperemic optic discs; disc pseudo-oedema and microangiopathy leading to optic disc atrophy. The analyses of the stability of protein upon identified mutations using DynaMut tool server demonstrated that these variations induce a rigidification in the region where they are located.

Conclusion: This is the first Tunisian report of mtDNA mutations identified in Tunisia causing the LHON. The main factors involved in the pathophysiological mechanisms of this disease are genetic, epigenetic, hormonal and environmental influences.

References

Rodrigues C, Pires D, Ascher D . DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018; 46(W1):W350-W355. PMC: 6031064. DOI: 10.1093/nar/gky300. View

Amri Y, Dabboubi R, Khemiri M, Jebabli E, Hadj Fredj S, Ben Ahmed S . Catalyzing precision: unraveling the diagnostic conundrum of tunisian familial hypophosphatasia case through integrative clinical and molecular approaches. Mol Genet Genomics. 2024; 299(1):64. DOI: 10.1007/s00438-024-02157-y. View

Sugisaka E, Ohde H, Shinoda K, Mashima Y . Woman with atypical unilateral Leber's hereditary optic neuropathy with visual improvement. Clin Exp Ophthalmol. 2008; 35(9):868-70. DOI: 10.1111/j.1442-9071.2007.01628.x. View

Fruhman G, Landsverk M, Lotze T, Hunter J, Wangler M, Adesina A . Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Mol Genet Metab. 2011; 103(2):153-60. DOI: 10.1016/j.ymgme.2011.02.014. View

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

Caporali L, Iommarini L, La Morgia C, Olivieri A, Achilli A, Maresca A . Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber's hereditary optic neuropathy. PLoS Genet. 2018; 14(2):e1007210. PMC: 5828459. DOI: 10.1371/journal.pgen.1007210. View

Stramkauskaite A, Povilaityte I, Glebauskiene B, Liutkeviciene R . Clinical Overview of Leber Hereditary Optic Neuropathy. Acta Med Litu. 2022; 29(1):9-18. PMC: 9428633. DOI: 10.15388/Amed.2022.29.1.19. View

Sotiriou E, Coku J, Tanji K, Huang H, Hirano M, DiMauro S . The m.3244G>A mutation in mtDNA is another cause of progressive external ophthalmoplegia. Neuromuscul Disord. 2009; 19(4):297-9. PMC: 2699630. DOI: 10.1016/j.nmd.2009.01.014. View

Hu J, Hsu C, Hsiao Y, Lin Y, Lai W, Liu Y . Leber's hereditary optic neuropathy: Update on the novel genes and therapeutic options. J Chin Med Assoc. 2023; 87(1):12-16. DOI: 10.1097/JCMA.0000000000001031. View

10.

Bahr T, Welburn K, Donnelly J, Bai Y . Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(6):165743. PMC: 9252426. DOI: 10.1016/j.bbadis.2020.165743. View

11.

Bellaousov S, Reuter J, Seetin M, Mathews D . RNAstructure: Web servers for RNA secondary structure prediction and analysis. Nucleic Acids Res. 2013; 41(Web Server issue):W471-4. PMC: 3692136. DOI: 10.1093/nar/gkt290. View

12.

Puomila A, Hamalainen P, Kivioja S, Savontaus M, Koivumaki S, Huoponen K . Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007; 15(10):1079-89. DOI: 10.1038/sj.ejhg.5201828. View

13.

Karaarslan C . Leber's Hereditary Optic Neuropathy as a Promising Disease for Gene Therapy Development. Adv Ther. 2019; 36(12):3299-3307. PMC: 6860503. DOI: 10.1007/s12325-019-01113-2. View

14.

Kirches E . LHON: Mitochondrial Mutations and More. Curr Genomics. 2011; 12(1):44-54. PMC: 3129042. DOI: 10.2174/138920211794520150. View

15.

Wilson V, Kaur P, Singh S, Ramachandran R, Jyothi V, Mahesh K . Clinical Profile of Patients with Leber Hereditary Optic Neuropathy (LHON): An Ambispective Study of North Indian Cohorts. Ann Indian Acad Neurol. 2023; 25(Suppl 2):S65-S69. PMC: 9795704. DOI: 10.4103/aian.aian_532_22. View

16.

Iorga R, Munteanu-Danulescu R, Danielescu C . A challenging differential diagnosis - Leber's Hereditary Optic Neuropathy. Rom J Ophthalmol. 2024; 68(1):65-71. PMC: 11007558. DOI: 10.22336/rjo.2024.13. View

17.

Carta A, Carelli V, DAdda T, Ross-Cisneros F, Sadun A . Human extraocular muscles in mitochondrial diseases: comparing chronic progressive external ophthalmoplegia with Leber's hereditary optic neuropathy. Br J Ophthalmol. 2005; 89(7):825-7. PMC: 1772744. DOI: 10.1136/bjo.2004.060590. View

18.

Rudolph G, Dimitriadis K, Buchner B, Heck S, Al-Tamami J, Seidensticker F . Effects of idebenone on color vision in patients with leber hereditary optic neuropathy. J Neuroophthalmol. 2012; 33(1):30-6. PMC: 3658961. DOI: 10.1097/WNO.0b013e318272c643. View

19.

Mahmoud T, Sahli C, Hadj Fredj S, Amri Y, Othmani R, Mohamed G . Epidemiological and molecular study of hemoglobinopathies in Mauritanian patients. Mol Genet Genomic Med. 2022; 10(10):e2048. PMC: 9544207. DOI: 10.1002/mgg3.2048. View

20.

Guex N, Peitsch M . SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1998; 18(15):2714-23. DOI: 10.1002/elps.1150181505. View